EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 3)
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT06160349
- Status
- Enrolling By Invitation
Conditions
- Infections
- Maternal Sepsis
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Sepsis is the second leading cause of maternal death in the U.S. For racial and ethnic minoritized birthing people, especially those who are Black, living in poverty, and from underserved communities, labor and postpartum are particularly vulnerable risk periods. The goal of this multi-center, multidisciplinary observational study is to establish a novel maternal care continuity model to reduce sepsis- related death and disability and increase maternal health equity.
Key Dates
- Start date
- Jul 20, 2023
- Status verified
- Jan 2026
- Primary completion
- Aug 31, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Patient InterviewsPatients with risk factors for maternal sepsis interviewed about pregnancy, labor/delivery, and postpartum via Zoom.
- Arm: Community StakeholdersCommunity stakeholders with professional and/or academic backgrounds relevant to maternal health who participate in focus group discussion.
Primary Outcome Measure
Integrative Supportive Care Model [ Time Frame: 2023-2025 ]
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia Unviersity Medical Center | New York | New York | 10032 | - |
| NYC Health+Hospitals/Harlem | New York | New York | 10037 | - |
| NYC Health + Hospitals/Lincoln | The Bronx | New York | 10451 | - |
Find similar trials in New York, NY
Related Studies
- Exactech Shoulder Post Market Clinical Follow-up StudyRecruiting · Exactech · Laguna Woods, California
- PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After FixationPHASE3 · Recruiting · Major Extremity Trauma Research Consortium · Indianapolis, Indiana
- Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)PHASE2 · Recruiting · BioAegis Therapeutics Inc. · Irvine, California
- EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)Recruiting · Columbia University · New York, New York